Health Canada instructed the Star it has contacted Adastra to “reiterate the really slim parameters in their licence.” The corporate subsequently issued a 2nd release Friday retracting what it claimed in its very first assertion and noting: “These statements really should not be relied upon.”You could end up with a drug that contains wrong